Tag: Inogen
In brief: Medline’s IPO, GLP-1's expansion, DME’s ‘hidden cost,’ Nymbl’s investment
January 3, 2025HME News Staff
NORTHFIELD, Ill. – Medline has confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.
The number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC's review process.
In 2021, Medline announced it had received outside...
Inogen OK’d to supply airway clearance device
December 30, 2024HME News Staff
GOLETA, Calif. – Inogen has received 510(k) clearance from the U.S. Food and Drug Administration for the Simeox 200 Airway Clearance Device, expanding the company’s ability to market and meet the various needs of patients with chronic respiratory diseases in the U.S.
Inogen entered into a definitive agreement to acquire Physio-Assist SAS, a privately held company based in France that makes the technology-enabled Simeox for $32 million in 2023.
“We are very...
Inogen remains focused on growth, innovation, profitability
November 7, 2024HME News Staff
GOLETA, Calif. - Inogen reported total revenue of $88.8 million for the third quarter of 2024, a 5.8% increase year over year, driven by higher demand and new customer gains across the domestic and international business-to-business channels.
Those gains were partially offset by lower direct-to-consumer sales and rental revenue.
“We continued to make significant progress on our strategic priorities in the third quarter,” said Kevin Smith, president and CEO. Our...
In brief: Sunrise acquisition, sleep apnea survey, standing letter, IV shortage
October 11, 2024HME News Staff
FRESNO, Calif. – Sunrise Medical has acquired Nuprodx, a California-based manufacturer of bathroom mobility products, including a patented shower tub slider system for mobility impaired users.
The acquisition strengthens Sunrise Medical’s portfolio by adding Nuprodx’s bathroom mobility solutions to its existing broad range of assistive mobility solutions.
“Nuprodx’s innovative bathroom mobility products perfectly align with our mission...
Inogen launches Rove 4
October 9, 2024HME News Staff
GOLETA, Calif. – Inogen has launched its Inogen Rove 4 Portable Oxygen Concentrator, a lightweight, user-friendly device with an additional fourth flow setting delivering up to 840ml/min of oxygen. “We are pleased to announce the launch of Rove 4, a meaningful step forward in our intent to serve patients in need of oxygen therapy while allowing them to remain ambulatory,” said Kevin Smith, president and CEO. “This is an important milestone, and we are excited to work with...
Inogen’s new sales exec seeks ‘deeper connection’ with HME customers
October 4, 2024Liz Beaulieu, Editor
GOLETA, Calif. – The addition of Eric Pauls to Inogen’s executive team well positions the manufacturer of respiratory therapy products for the launch of its Simeox airway clearance device in the United States, pending regulatory clearance.
Pauls, Inogen’s new vice president of sales for North America, was previously senior vice president of sales for Tactile Medical, which manufactures the AffloVest high frequency chest wall oscillation device, which treats a similar patient...
Inogen names Pauls to VP role
September 9, 2024HME News Staff
GOLETA, Cailf. – Inogen has appointed Eric Pauls, formerly of Tactile Medical and Philips, as its vice president of sales, North America. “Eric’s extensive experience at Tactile Medical and Philips will be a powerful addition to our existing U.S. business-to-business and prescriber sales teams,” said Gregoire Ramade, chief commercial officer. “As we advance toward the introduction of Simeox to the U.S. market, Eric’s experience with the respiratory business will...
Inogen takes ‘steps in right direction’
August 9, 2024Liz Beaulieu, Editor
GOLETA, Calif. – Inogen reported strong financial results for the second quarter, including a 6% increase in revenue year over year and a 14% increase sequentially, as the company continues to fine tune its business model.
During a recent conference call, CEO Kevin Smith again highlighted pilot programs to 1) target hospitals, in addition to individual practitioners, as referral sources in its rental channel; and 2) cross-train its sales reps to execute both cash and insurance transactions...
Inogen makes ‘meaningful progress’
August 6, 2024HME News Staff
GOLETA, Calif. – Inogen reported total revenue increased 6.1% to $88.8 million for the second quarter, primarily driven by higher demand and new customers in international and domestic business-to-business sales.
It reported a net loss of $5.59 million vs. a net loss of $9.83 million year over year.
“I am proud of the performance of our team in the first half of 2024,” said Kevin Smith, president and CEO. “We have made meaningful progress on our strategic...
Inogen names Kevin Smith general counsel, EVP
July 8, 2024HME News Staff
GOLETA, Calif. - Inogen has appointed Kevin P. Smith as general counsel and executive vice president of business development, effective July 22. He joins Inogen from Sirtex Medical, where he served as general counsel and executive vice president, business development, since 2018. “Kevin will be an invaluable addition to our leadership team at Inogen,” said Kevin Smith, president and CEO. “His extensive experience in the medical device and securities field will play an important...